CBL and hepatocellular carcinoma: As EGFR ubiquitination by c-CBL leads to EGFR degradation, blocking EGFR ubiquitination results in maintenance of EGFR activation, leading to the stimulation of Treg differentiation and thus promoting HCC immune evasion [27].